Search research articles
Contact Us
Filters
Showing results (11-20 of 149) with videos related to
Page
of 15
Sort By:
The Annals of Pharmacotherapy
|
March 20, 1999
Rho Chi lecture. Pharmaceutical sciences in the next millennium
D J Triggle
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica
|
May 1, 1996
Depolarization as a regulatory signal at voltage-gated calcium channels
D J Triggle
Journal of Cardiovascular Pharmacology
|
January 1, 1991
Calcium-channel drugs: structure-function relationships and selectivity of action
D J Triggle
Clinical Therapeutics
|
November 1, 1995
Angiotensin II receptor antagonism: losartan - sites and mechanisms of action
D J Triggle
American Journal of Hypertension
|
June 2, 1998
The physiological and pharmacological significance of cardiovascular T-type, voltage-gated calcium channels
D J Triggle
Chirality
|
January 1, 1994
On the other hand: the stereoselectivity of drug action at ion channels
D J Triggle
The American Journal of Cardiology
|
November 7, 1996
Pharmacologic and therapeutic differences among calcium channel antagonists: profile of mibefradil, a new calcium antagonist
D J Triggle
Cleveland Clinic Journal of Medicine
|
November 1, 1992
Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance
D J Triggle
The American Journal of Cardiology
|
September 30, 1986
Antihypertensive mechanism of action and binding sites of nitrendipine
D J Triggle
Canadian Journal of Physiology and Pharmacology
|
April 1, 1977
The action of diazoxide analogs on aortic reactivity in normotensive and spontaneously hypertensive rats
S Chona, D J Triggle
Page
of 15
Search research articles
Search
Showing results (11-20 of 149) with videos related to
Sort By:
Page
of 15
The Annals of Pharmacotherapy
|
March 20, 1999
Rho Chi lecture. Pharmaceutical sciences in the next millennium
D J Triggle
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica
|
May 1, 1996
Depolarization as a regulatory signal at voltage-gated calcium channels
D J Triggle
Journal of Cardiovascular Pharmacology
|
January 1, 1991
Calcium-channel drugs: structure-function relationships and selectivity of action
D J Triggle
Clinical Therapeutics
|
November 1, 1995
Angiotensin II receptor antagonism: losartan - sites and mechanisms of action
D J Triggle
American Journal of Hypertension
|
June 2, 1998
The physiological and pharmacological significance of cardiovascular T-type, voltage-gated calcium channels
D J Triggle
Chirality
|
January 1, 1994
On the other hand: the stereoselectivity of drug action at ion channels
D J Triggle
The American Journal of Cardiology
|
November 7, 1996
Pharmacologic and therapeutic differences among calcium channel antagonists: profile of mibefradil, a new calcium antagonist
D J Triggle
Cleveland Clinic Journal of Medicine
|
November 1, 1992
Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance
D J Triggle
The American Journal of Cardiology
|
September 30, 1986
Antihypertensive mechanism of action and binding sites of nitrendipine
D J Triggle
Canadian Journal of Physiology and Pharmacology
|
April 1, 1977
The action of diazoxide analogs on aortic reactivity in normotensive and spontaneously hypertensive rats
S Chona, D J Triggle
Page
of 15